FzioMed is a privately held medical device company engaged in the development and commercialization of synthetic, absorbable surgical biomaterials. The companys product platform is a polymer technology called Oxiplex. The properties of Oxiplex make it an ideal and versatile biosurgery material. Oxiplex products are developed for use in adhesion prevention, in tissue healing, as injectables and coatings and for the delivery of drugs, targeting a variety of compelling markets. FzioMed s management and personnel is experienced in developing, manufacturing and commercializing medical products, with specialization in the design and production of polymeric biomaterials. Headquartered in San Luis Obispo, Calif., FzioMed is a privately owned company that employs nearly 25 people.